LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 108 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,422 | -39.7% | 182,561 | -27.9% | 0.00% | -50.0% |
| Q2 2023 | $357,118 | -1.2% | 253,275 | +5.1% | 0.00% | 0.0% |
| Q1 2023 | $361,533 | +18.0% | 241,022 | -8.0% | 0.00% | 0.0% |
| Q4 2022 | $306,425 | -6.0% | 261,902 | -9.2% | 0.00% | 0.0% |
| Q3 2022 | $326,000 | +52.3% | 288,299 | +113.0% | 0.00% | +100.0% |
| Q2 2022 | $214,000 | +1088.9% | 135,328 | +1027.7% | 0.00% | – |
| Q1 2022 | $18,000 | +28.6% | 12,000 | -17.8% | 0.00% | – |
| Q3 2020 | $14,000 | -71.4% | 14,601 | -74.2% | 0.00% | – |
| Q2 2020 | $49,000 | +16.7% | 56,541 | +11.5% | 0.00% | – |
| Q1 2020 | $42,000 | +110.0% | 50,718 | +129.0% | 0.00% | – |
| Q4 2019 | $20,000 | – | 22,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $41,223,872 | 3.66% |
| Raffles Associates | 1,587,739 | $1,873,532 | 2.48% |
| Defender Capital, LLC. | 5,184,510 | $6,117,722 | 2.22% |
| Prescott General Partners LLC | 1,851,851 | $2,185,184 | 0.14% |
| DCF Advisers, LLC | 82,751 | $97,646 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $63,450 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $922,484 | 0.02% |
| Fort Sheridan Advisors LLC | 83,931 | $99,039 | 0.02% |
| MAI Capital Management | 954,688 | $1,126,532 | 0.02% |
| Piscataqua Savings Bank | 12,499 | $14,623 | 0.01% |